Lemaitre Vascular (LMAT) Gross Margin (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Gross Margin for 17 consecutive years, with 72.13% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Gross Margin rose 211.0% year-over-year to 72.13% in Q2 2026; TTM through Jun 2026 was 72.9%, a 379.0% increase from a year earlier, with the FY2025 full-year figure at 71.53%, up 290.0% from the prior year.
• Gross Margin was 72.13% for Q2 2026 at Lemaitre Vascular, down from 72.72% in the prior quarter.
• Over five years, Gross Margin peaked at 75.28% in Q3 2025 and troughed at 63.62% in Q4 2022.
• A 5-year average of 68.21% and a median of 68.31% in 2023 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin sank 209 bps in 2022 and surged 746 bps in 2025, its largest moves.
• Over 5 years, Gross Margin stood at 63.62% in 2022, then gained by 7 bps to 68.05% in 2023, then increased by 2 bps to 69.26% in 2024, then climbed by 3 bps to 71.66% in 2025, then climbed by 1 bps to 72.13% in 2026.
• The last three Gross Margin figures came in at 72.13% (Q2 2026), 72.72% (Q1 2026), and 71.66% (Q4 2025), per Business Quant data.